-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5

Benzinga·05/12/2026 18:47:01
Listen to the news
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and raises the price target from $3.25 to $5.